← Evidence map

ArticleDermatology and therapy2025

Efficacy and Tolerability of a New Facial 2-Mercaptonicotinoyl Glycine-Containing Depigmenting Serum Versus Hydroquinone 4% over 3-Month Treatment of Facial Melasma.

Thierry Passeron et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2025
2026
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 40586974